A

Annovis Bio

D
ANVS
USD
0.31
(3.6993%)
Market Closed
4,035.00
Volume
-1.7
EPS
-
Div Yield
-1.914097
P/E
113,439,416.42
Market Cap
Today
3.6993%
1 Week
3.084%
1 Month
-3.013%
6 Months
-3.444%
12 Months
-17.630%
Year To Date
-53.653%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRK
MRK
-1.44
(-1.2137%)
USD
BMY
BMY
-0.72
(-1.4475%)
USD
PFE
PFE
-0.09
(-0.3025%)
USD
ABBV
ABBV
0.73
(0.3784%)
USD
AZN
AZN
0.32
(0.4072%)
USD
GSK
GSK
-0.78
(-1.8383%)
USD
JNJ
JNJ
-1.31
(-0.7883%)
USD
NVS
NVS
-0.02
(-0.0172%)
USD

Title:
Annovis Bio

Sector:
Healthcare
Industry:
Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
Do you need help or have a question?
Contact Us